Skip to main content

Table 2 Main parameters recorded at baseline and at 6 months with p values for significant paired comparisons

From: Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance

  Baseline 6 months p-value
Main medications
 - Beta-blockers 100 (83%) 101 (84%)  
 - ACE inhibitors 103 (85%) 104 (86%)
 - Statins 110 (91%) 105 (87%)
 - Antiplatelet therapy 120 (99%) 115 (95%)
Body mass index (kg.m−2) 25 ± 4 25 ± 4  
Heart rate (bpm) 66 ± 11 57 ± 8 < 0.001
BP parameters
 Systolic BP (mmHg) 129 ± 21 130 ± 20  
 Diastolic BP (mmHg) 75 ± 14 72 ± 11
 Mean BP (mmHg) 93 ± 15 92 ± 13
Cardiac parameters
 LV end-diastolic volume (mL.m−2) 92 ± 15 96 ± 18 0.006
 LV ejection fraction (%) 42 ± 8 49 ± 9 < 0.001
 Total MI area (% of LV) 22 ± 12 16 ± 11 < 0.001
 Transmural MI - presence (%) 94 (78%) 55 (46%) < 0.001
  - area (% of LV) 16 ± 13 8 ± 11 < 0.001
 MVO - presence (%) 59 (49%) 0 (0%) < 0.001
  - area (% of LV) 8 ± 11 0 ± 0 < 0.001
SV-derived parameters
 SV (mL.m−2) 38 ± 8 47 ± 9 < 0.001
 Cardiac index (L.min−1.m−2) 2.4 ± 0.4 2.6 ± 0.5 < 0.001
 TPVR (mmHg.min.m2.L−1) 39 ± 11 36 ± 9 0.001
 TAC (mL.m−2.mmHg−1) 0.74 ± 0.21 0.83 ± 0.22 < 0.001
 Ea (mmHg.m2.mL−1) 2.6 ± 0.9 2.1 ± 0.6 < 0.001
 Stroke Work (L.mmHg.m−2) 3.5 ± 0.9 4.3 ± 1.0 < 0.001
  1. ACE angiotensin converting enzyme, BP blood pressure, Ea effective arterial elastance, LV left ventricular, MI myocardial infarction, MVO microvascular obstruction, SV stroke volume, TAC total arterial compliance, TPVR total peripheral vascular resistance